Related Experiment Video
Updated: Jun 8, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Computational analysis of HIV-1 protease protein binding pockets
Gene M Ko1, A Srinivas Reddy, Sunil Kumar
1Computational Science Research Center, San Diego State University, San Diego, California, USA.
Journal of Chemical Information and Modeling
|October 8, 2010
Summary
HIV-1 protease mutations complicate treatment by altering drug binding. This study analyzed crystal structures and binding pockets, finding in vitro mutation patterns reflect in vivo data and revealing key structural features for drug design.
Area of Science:
- Structural Biology
- Virology
- Computational Chemistry
Background:
- Mutations in Human Immunodeficiency Virus type 1 (HIV-1) protease are a significant challenge in effective HIV treatment, as they can impede the binding of protease inhibitors.
- Understanding the structural basis of these mutations is crucial for developing more robust therapeutic strategies against HIV.
Purpose of the Study:
- To analyze the structural changes in HIV-1 protease resulting from mutations.
- To correlate in vitro observed mutation patterns with in vivo data.
- To identify key structural features of the HIV-1 protease binding pocket relevant to protease inhibitor efficacy using data mining.
Main Methods:
- Analysis of 68 HIV-1 protease crystal structures complexed with FDA-approved inhibitors from the Protein Data Bank (PDB).
- Development and application of a mutation map to identify and visualize mutational changes compared to the wild-type HXB2 strain.
- Data mining techniques including Random Forest (RF), Linear Discriminant Analysis (LDA), and Logistic Regression (LR), along with hybrid RF-LDA and RF-LR models, were used to analyze binding pocket chemical descriptors.
Main Results:
- In vitro mutation patterns derived from crystal structures were found to be representative of major in vivo mutations observed in patients.
- Data mining and clustering analysis identified critical structural features within the binding pockets that influence the conformation and binding of protease inhibitors.
- Hybrid models effectively reduced the descriptor space, highlighting the most relevant features for classification.
Conclusions:
- The study successfully links in vitro structural data with in vivo mutational outcomes in HIV-1 protease.
- Key structural determinants of protease inhibitor binding have been elucidated, offering insights beyond traditional genomic analysis.
- This work provides a foundation for understanding drug resistance mechanisms and designing next-generation HIV protease inhibitors.
Related Concept Videos
02:04Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
01:49Conserved Binding Sites
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:16Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...